Advertisement

Biological Mechanisms of Somatization

  • Kyung Bong Koh
Chapter

Abstract

Biological mechanisms of somatization include physiological activities, alterations in blood flow and endocrine system, physiological arousal induced by stress, pain threshold, gate control mechanism, brain imaging and electroencephalogram (EEG), abnormalities in cerebral hemispheres and hemispheric asymmetry, disturbances in wakefulness and concentration, serotonin, immunity, and genetic factors. Some of biological mechanisms may help differentiate between somatizing disorders and other mental disorders, such as depressive disorders and anxiety disorders. Further studies are needed to elucidate the brain-immune and genetic-immune interactions in these disorders.

Keywords

Biological mechanisms Somatization Somatizing disorders Depressive disorders Anxiety disorders 

References

  1. 1.
    Nutt DJ, Stein DJ. Understanding the neurobiology of comorbidity in anxiety disorders. CNS Spectr. 2006;11:13–20.CrossRefGoogle Scholar
  2. 2.
    Kellner R. Psychosomatic syndromes and somatic symptoms. Washington, DC: American Psychiatric Press; 1991. p. 187–225.Google Scholar
  3. 3.
    Toouli J. Sphincter of Oddi motility. Br J Surg. 1984;71:251–6.CrossRefGoogle Scholar
  4. 4.
    Holdstock DJ, Misiewicz JJ, Waller SL. Observation on the mechanism of abdominal pain. Gut. 1969;10:19–31.CrossRefGoogle Scholar
  5. 5.
    Fujii S, Kachi T, Sobue I. Chronic headache: its psychosomatic aspect. Jpn J Psychosom Med. 1981;21:411–9.Google Scholar
  6. 6.
    Anderson CD. Expression of affect and physiological response in psychosomatic patients. J Psychosom Res. 1981;25:143–9.CrossRefGoogle Scholar
  7. 7.
    Lacey JI, Lacey BC. Verification and extension of the principle of autonomic response-stereotype. Am J Psychol. 1958;71:50–73.CrossRefGoogle Scholar
  8. 8.
    Lacey JI, Bateman DE, Van Lehn R. Autonomic response specificity: an experimental study. Psychosom Med. 1953;15:8–21.CrossRefGoogle Scholar
  9. 9.
    Merskey H, Spear FG. Pain: psychological and psychiatric aspects. London: Ballire, Tindall and Cassell; 1967.Google Scholar
  10. 10.
    Bianchi GN. Origins of disease phobia. Aust NZJ Psychiatry. 1971;5:241–57.CrossRefGoogle Scholar
  11. 11.
    Droste C, Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol. 1983;1:940–5.CrossRefGoogle Scholar
  12. 12.
    Glazier JJ, Chierchia S, Brown MJ, et al. Importance of generalized defective perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable angina pectoris. Am J Cardiol. 1986;58:667–72.CrossRefGoogle Scholar
  13. 13.
    Guggenheim FG. Somatoform disorder. In: Sadock BJ, Sadock VA, editors. Comprehensive textbook of psychiatry. 7th ed. Baltimore: Lippincott Williams & Wilkins; 2000.Google Scholar
  14. 14.
    Lazarus A, Cotterell KP. SPECT scan reveals abnormality in somatization disorder patient. J Clin Psychiatry. 1989;50:475–6.PubMedGoogle Scholar
  15. 15.
    James L, Singer A, Zurynski Y, et al. Evoked potentials and regional cerebral blood flow in somatization disorder. Psychother Psychosom. 1987;47:190–6.CrossRefGoogle Scholar
  16. 16.
    Koh KB, Kang JI, Lee JD, et al. Shared neural activity in panic disorder and undifferentiated somatoform disorder compared with healthy controls. J Clin Psychiatry. 2010;71:1576–81.CrossRefGoogle Scholar
  17. 17.
    Hakala M, Karlsson H, Ruotsalainen U, et al. Somatization in women is associated with altered brain glucose metabolism. Psychol Med. 2002;32:1379–85.CrossRefGoogle Scholar
  18. 18.
    Hakala M, Karlsson H, Kurki T, et al. Volumes of the caudate nuclei in women with somatization disorder and healthy women. Psychiatry Res Neuroimaging. 2004;131:71–8.CrossRefGoogle Scholar
  19. 19.
    Gundel H, Valet M, Sorg C, et al. Altered cerebral response to noxious heat stimulation in patients with somatoform pain disorder. Pain. 2008;137:413–21.CrossRefGoogle Scholar
  20. 20.
    Rainville P, Duncan GH, Price DD, et al. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science. 1997;277:968–71.CrossRefGoogle Scholar
  21. 21.
    Wager TD, Rilling JK, Smith EE, et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science. 2004;303:1162–7.CrossRefGoogle Scholar
  22. 22.
    Schreckenberger M, Siessmeier T, Viertmann A, et al. The unpleasantness of tonic pain is encoded by the insular cortex. Neurology. 2005;64:1175–83.CrossRefGoogle Scholar
  23. 23.
    Treede RD. Assessment of pain as an emotion in animals and in humans. Exp Neurol. 2006;197:1–3.CrossRefGoogle Scholar
  24. 24.
    LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci. 2000;23:155–84.CrossRefGoogle Scholar
  25. 25.
    Price DD. Psychological and neural mechanisms of the affective dimension of pain. Science. 2000;288:1769–72.CrossRefGoogle Scholar
  26. 26.
    Sandkuhler J. Learning and memory in pain pathways. Pain. 2000;88:113–8.CrossRefGoogle Scholar
  27. 27.
    Valet M, Gundel H, Sprenger T, et al. Patients with pain disorder show gray-matter loss in pain-processing structures: a voxel-based morphometric study. Psychosom Med. 2009;71:49–56.CrossRefGoogle Scholar
  28. 28.
    Stoeter P, Bauermann T, Nickel R, et al. Cerebral activation in patients with somatoform pain disorder exposed to pain and stress: an fMRI study. NeuroImage. 2007;36:418–30.CrossRefGoogle Scholar
  29. 29.
    Flor-Henry P, Fromm-Auch D, Tapper M, et al. A neuropsychological study of the stable syndrome of hysteria. Biol Psychiatry. 1981;16:601–26.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Hoppe KD. Split brains and psychoanalysis. Psychoanal Q. 1977;46:220–44.CrossRefGoogle Scholar
  31. 31.
    Galin D, Diamond R, Braff D. Lateralization of conversion symptoms: more frequent on the left. Am J Psychiatry. 1997;134:578–80.Google Scholar
  32. 32.
    Mersky H, Watson GD. The lateralization of pain. Pain. 7:271–80.Google Scholar
  33. 33.
    Heilman KM. Neglect and related disorders. In: Heilman KM, Balenstein E, editors. Clinical neuropsychology. New York: Oxford University Press; 1979.Google Scholar
  34. 34.
    Whitlock F. The aetiology of hysteria. Acta Psychiatr Scand. 1967;43:144–62.CrossRefGoogle Scholar
  35. 35.
    Miller L. Neuropsychological concepts of somatoform disorders. Int J Psychiatry Med. 1984;14:31–46.CrossRefGoogle Scholar
  36. 36.
    Rief W, Pilger F, Ihle D, et al. Psychobiological aspects of somatoform disorders: contributions of monoaminergic transmitter systems. Neuropsychobiology. 2004;49:24–9.CrossRefGoogle Scholar
  37. 37.
    Kronfol A, Silva J, Gredin J, et al. Impaired lymphocyte function in depressive illness. Life Sci. 1983;33:241–7.CrossRefGoogle Scholar
  38. 38.
    Kronfol Z, House JD. Depression, cortisol, and immune function. Lancet. 1984;1:1026–7.CrossRefGoogle Scholar
  39. 39.
    Krueger RB, Levy EM, Cathcart ES. Lymphocyte subsets in patients with major depression: preliminary findings. Advances. 1984;1:5–9.Google Scholar
  40. 40.
    Andreoil A, Keller SE, Taban C, et al. Immune function in major depressive disorder: relation to panic disorder comorbidity. Biol Psychiatry. 1990;27(Suppl):9A–95A.Google Scholar
  41. 41.
    Brambilla F, Bellodi L, Perna G, et al. Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology. 1992;26:12–22.CrossRefGoogle Scholar
  42. 42.
    La Via MF, Munno I, Lydiard RB, et al. The influence of stress intrusion on immunodepression in generalized anxiety disorder patients and controls. Psychosom Med. 1996;58:138–42.CrossRefGoogle Scholar
  43. 43.
    Koh KB, Lee BK. Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosom Med. 1998;60:479–83.CrossRefGoogle Scholar
  44. 44.
    Rapaport MH. Circulating lymphocyte phenotypic surface markers in anxiety disorder patients and normal volunteers. Biol Psychiatry. 1998;43:458–63.CrossRefGoogle Scholar
  45. 45.
    Koh KB, Lee Y. Reduced anxiety level by therapeutic interventions and cell-mediated immunity in panic disorder patients. Psychother Psychosom. 2004;73:286–92.CrossRefGoogle Scholar
  46. 46.
    Koh KB, Sohn S-H, Kang JI, et al. Relationship between neural activity and immunity in patients with undifferentiated somatoform disorder. Psychiatry Res Neuroimaging. 2012;202:252–6.CrossRefGoogle Scholar
  47. 47.
    Rief W, Pilger F, Ihle D, et al. Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res. 2001;105:165–74.CrossRefGoogle Scholar
  48. 48.
    Kaplan HI, Sadock BJ. Synopsis of psychiatry. 8th ed. Baltimore: Williams & Wilkins; 1998.Google Scholar
  49. 49.
    Dantzer R. Somatization: a psychoneuroimmune perspective. Psychoneuroendocrinology. 2005;30:947–52.CrossRefGoogle Scholar
  50. 50.
    Houtveen JH, Kavelaars A, Heijnen CJ, et al. Heterogeneous medically unexplained symptoms and immune function. Brain Behav Immun. 2007;21:1075–82.CrossRefGoogle Scholar
  51. 51.
    Kang D-H, Davidson RJ, Coe CL, et al. Frontal brain asymmetry and immune function. Behav Neurosci. 1991;105:860–9.CrossRefGoogle Scholar
  52. 52.
    Davidson RJ, Coe CC, Dolski I, et al. Individual differences in prefrontal activation asymmetry predict natural killer cell activity at rest and in response to challenge. Brain. Behav Immun. 1999;13:93–108.CrossRefGoogle Scholar
  53. 53.
    Renoux G, Biziere K, Renoux M, et al. A balanced brain asymmetry modulates T cell-mediated events. J Neuroimmunol. 1983;5:227–38.CrossRefGoogle Scholar
  54. 54.
    Cadoret RJ. Psychopathology in adopted-away offspring of biologic parents with antisocial behavior. Arch Gen Psychiatry. 1978;35:176–84.CrossRefGoogle Scholar
  55. 55.
    Gottesman II. Differential inheritance of the psychoneuroses. Eugenics Q. 1962;9:223–67.CrossRefGoogle Scholar
  56. 56.
    Torgersen S. Genetics of somatoform disorders. Arch Gen Psychiatry. 1986;43:502–5.CrossRefGoogle Scholar
  57. 57.
    Koh KB, Choi EH, Lee Y, et al. Serotonin-related gene pathways associated with undifferentiated somatoform disorder. Psychiatry Res. 2011;189:246–50.CrossRefGoogle Scholar
  58. 58.
    Koh KB, Kim CH, Choi EH, et al. Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder. J Clin Psychiatry. 2012;73:e574–9.CrossRefGoogle Scholar
  59. 59.
    Rief W, Hennings A, Riemer S, et al. Psychobiological differences between depression and somatization. J Psychosom Res. 2010;68:495–502.CrossRefGoogle Scholar
  60. 60.
    Koh KB. Identity of somatoform disorders: comparison with depressive disorders and anxiety disorders. In: Koh KB, editor. Somatization and psychosomatic symptoms. New York: Springer; 2013.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Kyung Bong Koh
    • 1
  1. 1.Department of PsychiatryYonsei University College of MedicineSeoulKorea

Personalised recommendations